Background: Peritoneal metastasis (PM) from colorectal cancer (CRC) carries a poor prognosis. The Peritoneal Cancer Index (PCI) is among the principal prognostic stratification tools, yet the prognostic value of the anatomical distribution of disease beyond total PCI is underexplored. This pilot study evaluated whether quadrant-specific involvement adds prognostic information in patients undergoing cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), with a focused analysis of oligometastatic disease (PCI ≤ 6). Methods: A single-institution cohort of 48 CRC-PM patients treated with CRS + HIPEC was analyzed. Primary endpoints were OS, DFS, and PRFS, with a focused evaluation of the oligometastatic subset (PCI ≤ 6). Comparative statistics used Student’s two-sample t test for continuous variables and chi-square or two-sided Fisher’s exact tests for categorical variables. Survival was estimated by Kaplan–Meier with log-rank tests, and prognostic factors were evaluated using Cox regression. Results: Median follow-up was 177 months (IQR 87–224). Outcomes favored PCI ≤ 6: 5-year OS and DFS were 54% and 37.5% versus 6.6% and 0% for PCI > 6, and median OS 64 vs. 29 months (log-rank p = 0.007), median DFS 30 vs. 7 months (p = 0.0002), and median PRFS 26 vs. 8 months (p = 0.0002). In the PCI ≤ 6 subset (n = 27), quadrant 3 (left upper quadrant) was associated with higher recurrence risk and shorter DFS, remaining independently prognostic for DFS (p = 0.005) and PRFS (p = 0.005). For PRFS, quadrants 7 and 8 also showed associations on univariable analysis; Q7 remained independent (p = 0.047), whereas Q8 was borderline (p = 0.077). A histology-related signal at Q8 (p = 0.011) was exploratory due to very small mucinous and signet-ring strata. Sidedness and synchronicity yielded no significant differences in quadrant involvement within PCI ≤ 6. No quadrant effects were observed in PCI > 6. Conclusions: PCI remains the dominant prognostic determinant after CRS + HIPEC, yet in oligometastatic disease, the anatomical distribution adds complementary prognostic information, particularly involvement of Q3 and Q7. These findings are hypothesis-generating and warrant validation in larger, preferably multicenter cohorts with standardized quadrant mapping. If confirmed, quadrant-directed operative planning, including consideration of prophylactic resection in selected high-risk regions, could be prospectively evaluated.
Major hepatectomy (MH) has traditionally been associated with higher R0 rates in colorectal liver metastases (CRLM), but at the cost of increased morbidity. Parenchymal-sparing hepatectomy (PSH) has emerged as an alternative approach aimed at reducing perioperative complications while preserving functional liver parenchyma without compromising oncological outcomes. We retrospectively analyzed 248 consecutive patients undergoing liver resection for CRLM between 2016 and 2025, classified as PSH (n = 215, 86.7%) or MH (n = 33, 13.3%). MH was performed more frequently in patients with greater tumor burden, including larger lesions, more numerous metastases, and bilobar disease (all p < 0.001). PSH was associated with shorter hospital stay, fewer postoperative complications, and lower 30-day readmission rate. In multivariable Cox analyses, surgical strategy was not associated with recurrence-free survival or overall survival, which were primarily driven by tumor burden. Among patients who developed liver recurrence, repeat hepatectomy was more often feasible after PSH than MH (p = 0.026), emphasizing the long-term value of preserving functional parenchyma. Overall, PSH was associated with lower postoperative morbidity, enabling earlier recovery, while facilitating future liver resections when needed in this chronically evolving disease.
Malignant liver tumors are increasingly diagnosed in elderly patients owing to population aging. Surgical resection remains the only potentially curative treatment in most cases, but perioperative management in older individuals is complex because of reduced hepatic regenerative capacity, frailty, and comorbidities. Evidence shows that age alone should not preclude surgery, since carefully selected elderly patients can achieve survival outcomes comparable to younger cohorts. In fact, frailty and overall functional status represent more reliable predictors of postoperative risk than chronological age. Advances in surgical techniques, anesthesia, and minimally invasive approaches have expanded the safety and feasibility of hepatic resections in older patients, reducing complication rates and length of stay without compromising oncological results. Nonetheless, elderly patients remain more vulnerable to postoperative mortality, largely due to the greater impact of complications. A multidisciplinary, individualized evaluation—taking into account tumor biology, life expectancy, comorbidity burden, and frailty—is therefore essential to balance risks and benefits. With proper patient selection and the increased use of minimal invasive approaches, liver surgery can offer meaningful survival even in advanced age, reinforcing the principle that chronological age should not represent an absolute contraindication.
Background: Postpancreatectomy mortality (PPM) remains relatively unexplored after minimally invasive pancreatic surgery (MIPS). The International Study Group for Pancreatic Surgery (ISGPS) recently proposed a consensus definition and classification of PPM based on root-cause analysis. We aimed to assess the applicability of this classification and characterize mechanisms of PPM following MIPS. Methods: This study retrospectively analyzed consecutive patients undergoing MIPS enrolled in the Italian IGoMIPS registry (October 2019–July 2025). All PPM events were reviewed and attributed specific PPM types using structured root-cause analysis according to ISGPS criteria. Multivariable logistic regression identified predictors of PPM, and PPM type distributions were compared across procedures. Results: Out of 3590 patients, the PPM rate was 2.7%. Specifically, PPM occurred in 5.9% following minimally invasive pancreatoduodenectomy (MIPD), 0.8% following left pancreatectomy (MILP), and 4.8% following total pancreatectomy (MITP), while no PPM events occurred after parenchyma-sparing resections. Increased age and American Society of Anesthesiology Physical Status (ASA-PS) ≥3 independently predicted PPM. Root-cause analysis showed that most PPM followed cascades of multiple pancreatectomy-specific complications, predominantly postoperative pancreatic fistula (POPF) and postpancreatectomy hemorrhage (PPH). PPM 2 accounted for approximately two-thirds of deaths, particularly after MIPD and MITP, whereas PPM 1 and PPM 3 accounted for 13.3% and 15.3%, respectively. Conclusions: Mortality after MIPS predominantly occurs after a cascade of pancreatectomy-specific complications rather than technical failure or isolated medical events. Centers performing MIPS should invest in strategies to mitigate POPF and PPH and minimize failure to rescue once they occur.